Since the evaluation of the cryoballoon in the Sustained Treatment Of Paroxysmal Atrial Fibrillation trial, more than 350,000 patients with atrial fibrillation have been treated. Several studies have reported improved outcomes using the second-generation cryoballoon, and recent publications have evaluated modifications, refinements, and improvements in procedural techniques. Here, peer-reviewed articles published since the first cryoballoon best practices review were summarized against the technical practices of physicians with a high level of experience with the cryoballoon (average ≥6 years of experience in ≥900 cases). This summary includes a comprehensive literature review along with practical usage guidance from physicians using the cr...
Background: Cryoballoon ablation is a recently introduced technique to isolate the pulmonary veins i...
Abstract Background Effective treatment of paroxysmal atrial fibrillation (AF) is essential for redu...
Cryoablation is safe and effective for the treatment of atrial fibrillation (AF) in controlled clini...
BackgroundSince the release of the second-generation cryoballoon (CB2; Arctic Front AdvanceTM, Medtr...
Nowadays, the cryoballoon (CB) constitutes an established alternative to radio frequency (RF) ablati...
AbstractFocal point-by-point radiofrequency catheter ablation has shown considerable success in the ...
BACKGROUND: Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as t...
Cryoballoon ablation for the treatment of atrial fibrillation has established itself as an effective...
Atrial fibrillation (AF) is a common arrhythmia contributing to severe outcomes, including cardiac d...
Over the past decade, cryoballoon therapy has evolved into a well-recognized and recommended ablatio...
BackgroundWith the technical properties of the 2nd generation (Arctic Front Advance, AFA) cryoballoo...
BACKGROUND: In patients with symptomatic paroxysmal atrial fibrillation that has not responded to me...
Aims Pulmonary vein isolation (PVI), the standard for atrial fibrillation (AF) ablation, is most com...
The present review will discuss the technical aspects of a new patent invented in 1999 which allows ...
Background: The evaluation of novel energy sources for the treatment of paroxysmal atrial fibrillati...
Background: Cryoballoon ablation is a recently introduced technique to isolate the pulmonary veins i...
Abstract Background Effective treatment of paroxysmal atrial fibrillation (AF) is essential for redu...
Cryoablation is safe and effective for the treatment of atrial fibrillation (AF) in controlled clini...
BackgroundSince the release of the second-generation cryoballoon (CB2; Arctic Front AdvanceTM, Medtr...
Nowadays, the cryoballoon (CB) constitutes an established alternative to radio frequency (RF) ablati...
AbstractFocal point-by-point radiofrequency catheter ablation has shown considerable success in the ...
BACKGROUND: Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as t...
Cryoballoon ablation for the treatment of atrial fibrillation has established itself as an effective...
Atrial fibrillation (AF) is a common arrhythmia contributing to severe outcomes, including cardiac d...
Over the past decade, cryoballoon therapy has evolved into a well-recognized and recommended ablatio...
BackgroundWith the technical properties of the 2nd generation (Arctic Front Advance, AFA) cryoballoo...
BACKGROUND: In patients with symptomatic paroxysmal atrial fibrillation that has not responded to me...
Aims Pulmonary vein isolation (PVI), the standard for atrial fibrillation (AF) ablation, is most com...
The present review will discuss the technical aspects of a new patent invented in 1999 which allows ...
Background: The evaluation of novel energy sources for the treatment of paroxysmal atrial fibrillati...
Background: Cryoballoon ablation is a recently introduced technique to isolate the pulmonary veins i...
Abstract Background Effective treatment of paroxysmal atrial fibrillation (AF) is essential for redu...
Cryoablation is safe and effective for the treatment of atrial fibrillation (AF) in controlled clini...